1. Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER–/PR– Breast Cancers, a Chromosome 17 C-HPP Study
   Rajasree Menon et al, 2015, J. Proteome Res. CrossRef
2. Research Progress in Applying Proteomics Technology to Explore Early Diagnosis Biomarkers of Breast Cancer, Lung Cancer and Ovarian Cancer
   Lu Luo et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
3. Upregulation of NEK2 is associated with drug resistance in ovarian cancer
   XIA LIU et al, 2014 CrossRef
4. Distinct Splice Variants and Pathway Enrichment in the Cell-Line Models of Aggressive Human Breast Cancer Subtypes
   Rajasree Menon et al, 2014, J. Proteome Res. CrossRef
5. Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer
   Caixia Wang et al, 2019, BioMed Research International CrossRef
6. Innovations in proteomic profiling of cancers: Alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biology
   Gilbert S. Omenn et al, 2013, Journal of Proteomics CrossRef
7. The emerging era of genomic data integration for analyzing splice isoform function
   Hong-Dong Li et al, 2014, Trends in Genetics CrossRef
8. Towards improved genome-scale metabolic network reconstructions: unification, transcript specificity and beyond
   Thomas Pfau et al, 2015, Brief Bioinform CrossRef
9. Targeting the Right Protein Isoform: Mass Spectrometry‐Based Proteomic Characterization of Alternative Splice Variants
   Jiang Wu, 2017 CrossRef
10. RNAi screens identify CHD4 as an essential gene in breast cancer growth
    Carolina D'Alesio et al, 2016, Oncotarget CrossRef